Search

everythinglearnresearchcommunity

for

Search:↓

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

A blood pressure drug, diltiazem, may also help treat influenza.

Antibiotic ointment and petrolatum ointment heal wounds similarly; iron deficiency isn't linked to certain hair loss in women; griseofulvin and terbinafine are equally effective for fungal scalp infections but work better on different types.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The document concludes that skin and nail changes can indicate various underlying health conditions.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Effective symptom management in IBD improves quality of life and prevents complications.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

Iron chloride helps create compounds that could be useful in medicine, like treating hair loss.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

Besnoitiosis, a parasitic disease, has been found in donkeys in Italy and may be more common in Europe than previously thought.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.